Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Nov 27, 2023; 15(11): 2445-2455
Published online Nov 27, 2023. doi: 10.4240/wjgs.v15.i11.2445
Table 2 Relationship between preoperative systemic immune inflammatory index and clinicopathological features of patients undergoing radical resection of liver cancer
Indexes
Number of cases
SII
χ2
P value
> 309.14 (47 cases)
≤ 309.14 (53 cases)
Gender0.0020.965
    Male7033 (70.21)37 (69.81)
    Female3014 (29.79)16 (30.19)
Age0.0470.828
    ≤ 70 yr old3315 (31.91)18 (33.96)
    > 70 yr old6732 (68.09)35 (66.04)
Hepatitis B markers0.0970.755
    Negative2712 (25.53)15 (28.30)
    Positive7335 (74.47)38 (71.70)
Degree of differentiation4.6430.031
    Middle-low differentiation5520 (42.55)35 (66.04)
    High differentiation4527 (57.45)18 (33.96)
Maximum tumor diameter6.8070.033
     5 cm288 (17.02)20 (37.74)
    5-10 cm5427 (57.45)27 (50.94)
    > 10 cm1812 (25.53)6 (11.32)
Number of tumors0.0040.948
     3136 (12.77)7 (13.21)
    ≥ 38741 (87.23)46 (86.79)
Ascites0.8460.358
    No7939 (82.98)40 (75.47)
    Yes218 (17.02)13 (24.53)
Lymph node metastasis8.6870.003
    Yes3821 (44.68)17 (32.08)
    No6226 (55.32)36 (67.92)
TNM staging7.5170.006
    I–II5921 (44.68)38 (71.70)
    III–IV4126 (55.32)15 (28.30)
Envelope Integrity0.5250.469
    Complete5725 (53.19)32 (60.38)
    Incomplete4322 (46.81)21 (39.62)
Portal vein tumor thrombus0.2000.655
    Yes3214 (29.79)18 (33.96)
    No6833 (70.21)35 (66.04)
Child-Pugh classification0.4240.515
    A5427 (57.45)27 (50.94)
    B4620 (42.55)26 (49.06)
Alpha-fetoprotein expression0.1020.749
    Negative4321 (44.68)22 (41.51)
    Positive5726 (55.32)31 (58.49)